BPL 027 Pill: white, capsule/oblong
The pill with imprint BPL 027 (White, Capsule/Oblong, 0mm) has been identified as Flecainide Acetate 150 mg and is used for Atrial Fibrillation, Supraventricular Tachycardia, Atrial Flutter, Wolff-Parkinson-White Syndrome, and Paroxysmal Supraventricular Tachycardia. It belongs to the drug class group I antiarrhythmics and is not a controlled substance.
Images for BPL 027
Flecainide Acetate
- Imprint
- BPL 027
- Strength
- 150 mg
- Color
- White
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Group I antiarrhythmics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Bayshore Pharmaceuticals LLC
- Manufacturer
- Beximco Pharmaceuticals Ltd.
- National Drug Code (NDC)
- 76385-0147
See also:
More about flecainide
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (178)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Support group
- Drug class: group I antiarrhythmics
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.